Upload Avatar (500 x 500)
Fang Ni
fangni@ustc.edu.cn
English, Chinese
Anhui
University of Science and Technology of China
Basic Medical Sciences
  • 2013 - PhD: University of Science and Technology of China, School of Life Sciences
  • 2015-2019 - Postdoctoral Research: Emory University Hospital, USA
  • 2019-present - University of Science and Technology of China, School of Life Sciences and Medicine, Principal Investigator
Hematopoietic regulation and leukemia pathogenesis
NK cell immunotherapy
  • Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia., Wang Y, Huang B, Liang T, Jiang L, Wu M, Liu X, Zhu M, Song X, Zhao N, Wei H*, Zheng C*, Ni F*., 2024
  • Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19., Guo C#, Wu M#, Huang B#, Zhao R, Jin L, Fu B, Wang P, Wang D, Zheng M, Fang J, Wei H*, Qu K*, Ni F*., 2022
  • Ptpn21 controls hematopoietic stem cell homeostasis and biomechanics., Ni F, Yu WM, Wang XY, Fay ME, Young KM, Qiu YZ, Lam WA, Sulchek TA, Cheng T, Scadden DT, and Qu CK*., 2019
  • Critical role of ASCT2-mediated amino acid metabolism in promoting leukemia development and progression., Ni F, YuWM, Li ZG, GrahamDK, JinLT, Kang S, RossiMR, LiSY, BroxmeyerHE, and Qu CK*., 2019
  • IGF-1 promotes the development and cytotoxic activity of human NK cells., Ni F, Sun R, Fu B, Wang F, Guo C, Tian Z*, Wei H*., 2013
Hematopoiesis Leukemia Regulation Pathogenesis Nk Cells Immunotherapy Biomechanics Metabolism Multidisciplinary Homeostasis

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.